pharmaceutical development

SYDNEY, Australia — September 25, 2026 Aptar Pharma announced a new three-year research collaboration with Macquarie University supported by...

Bagsværd, Denmark, September 21, 2026 Novo Nordisk has announced topline results from two Phase 3 trials evaluating CagriSema, an...

Taipei, Taiwan, September 11, 2026 Avance Clinical has received the Australia-Taiwan Business Excellence Award from the Australia New Zealand...

Jerusalem, Israel, September 8, 2026 Scinai Immunotherapeutics has announced a strategic refocusing of its research and development portfolio following...

Chicago, Illinois, USA, September 8, 2026 Orphalan has initiated the global Phase 3 TRADITiONAL clinical trial evaluating an investigational...

Daejeon, South Korea, September 2, 2026 Alteogen Inc. has entered into an option and license agreement with Novartis to...

Tel Aviv, Israel, September 2, 2026 SciSparc Ltd. announced that its majority-owned subsidiary NeuroThera Labs Inc. is pursuing U.S....

SHANGHAI, China, Aug 28, 2026 Asieris Pharmaceuticals has released its 2026 Semi-Annual Report, highlighting progress in commercial operations, international...

Boston, MA, August 9, 2026 Asimov announced the successful completion of a cell line development campaign in collaboration with...

Mequon, Wisconsin & Lenexa, Kansas, July 28, 2026 Vector Science & Therapeutics Corp., LyoGenesis Plus 1, LLC, and Wynn...